Pier 88 Investment Partners LLC Recursion Pharmaceuticals, Inc. Transaction History
Pier 88 Investment Partners LLC
- $76.8 Million
- Q1 2025
A detailed history of Pier 88 Investment Partners LLC transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Pier 88 Investment Partners LLC holds 94,790 shares of RXRX stock, worth $416,128. This represents 0.65% of its overall portfolio holdings.
Number of Shares
94,790
Previous 161,730
41.39%
Holding current value
$416,128
Previous $1.09 Million
54.16%
% of portfolio
0.65%
Previous 1.45%
Shares
4 transactions
Others Institutions Holding RXRX
# of Institutions
365Shares Held
286MCall Options Held
3.28MPut Options Held
3.16M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl34.8MShares$153 Million1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA32.3MShares$142 Million0.0% of portfolio
-
Baillie Gifford & CO24.4MShares$107 Million0.12% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$76 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M014.7MShares$64.4 Million0.27% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $792M
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...